119 related articles for article (PubMed ID: 728374)
1. Quantitative abnormality of an Aalpha chain molecular weight form in the fibrinogen of cirrhotic patients.
Weinstein MJ; Deykin D
Br J Haematol; 1978 Dec; 40(4):617-30. PubMed ID: 728374
[TBL] [Abstract][Full Text] [Related]
2. Human fibrinogen heterogeneities: determination of the major Aalpha chain derivatives in blood.
Galanakis DK; Mosesson MW
Thromb Res; 1983 Aug; 31(3):403-13. PubMed ID: 20217997
[TBL] [Abstract][Full Text] [Related]
3. Dysfibrinogenemia associated with liver disease.
Palascak JE; Martinez J
J Clin Invest; 1977 Jul; 60(1):89-95. PubMed ID: 874092
[TBL] [Abstract][Full Text] [Related]
4. Study of the formation of fibrin clot in cirrhotic patients. An approach to study of acquired dysfibrinogenemia.
Regañón E; Vila V; Aznar J; Garrido G; Estellés A; Berenguer J
Thromb Res; 1987 Jun; 46(5):705-14. PubMed ID: 3629544
[TBL] [Abstract][Full Text] [Related]
5. Studies on the structural abnormality of fibrinogen Paris I.
Mosesson MW; Amrani DL; Ménaché D
J Clin Invest; 1976 Mar; 57(3):782-90. PubMed ID: 1249208
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen-fibrin conversion. The mechanism of fibrin-polymer formation in solution.
Smith GF
Biochem J; 1980 Jan; 185(1):1-11. PubMed ID: 7378042
[TBL] [Abstract][Full Text] [Related]
7. Purification of rat fibrinogen and its constituent chains.
Van Ruijven-Vermeer IA; Nieuwenhuizen W
Biochem J; 1978 Mar; 169(3):653-8. PubMed ID: 417720
[TBL] [Abstract][Full Text] [Related]
8. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
[TBL] [Abstract][Full Text] [Related]
9. The dimeric Aalpha chain composition of dysfibrinogenemic molecules with mutations at Aalpha 16.
Meh DA; Siebenlist KR; Galanakis DK; Bergtrom G; Mosesson MW
Thromb Res; 1995 Jun; 78(6):531-9. PubMed ID: 15714754
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of an abnormal fibrinogen by two-dimensional electrophoresis.
Polack B; Valiron O; Concord E; Freyssinet JM; Hudry-Clergeon G
Clin Chem; 1984 Dec; 30(12 Pt 1):2093-7. PubMed ID: 6499181
[TBL] [Abstract][Full Text] [Related]
11. Plasmic degradation of fibrinogen Paris I.
Budzynski AZ; Marder VJ
J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
[TBL] [Abstract][Full Text] [Related]
12. Residue gamma153Cys is essential for the formation of the complexes Aalphagamma and Bbetagamma, assembly intermediates for the AalphaBbetagamma complex and intact fibrinogen.
Terasawa F; Fujita K; Okumura N
Clin Chim Acta; 2005 Mar; 353(1-2):157-64. PubMed ID: 15698603
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin.
Marder VJ; Budzynski AZ; Barlow GH
Biochim Biophys Acta; 1976 Mar; 427(1):1-14. PubMed ID: 130927
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of an antiserum to the carboxymethylated Aalpha chain of human fibrinogen.
Conkie JA; Davidson JF
Thromb Haemost; 1978 Jun; 39(3):564-73. PubMed ID: 100895
[TBL] [Abstract][Full Text] [Related]
16. Evidence that heterodimers exist in the fibrinogen Matsumoto II (gamma308N-->K) proband and participate in fibrin fiber formation.
Okumura N; Terasawa F; Fujita K; Fujihara N; Tozuka M; Koh CS
Thromb Res; 2002 Aug; 107(3-4):157-62. PubMed ID: 12431483
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the terminal degradation products of canine fibrinogen by plasmin.
Chen JP; Hutchison HT; Nanninga LB; Guest MM
Biochim Biophys Acta; 1975 Mar; 386(1):69-79. PubMed ID: 123781
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome".
Mosesson MW; Siebenlist KR; Hainfeld Jf; Wall JS; Soria J; Soria C; Caen JP
J Clin Invest; 1996 May; 97(10):2342-50. PubMed ID: 8636415
[TBL] [Abstract][Full Text] [Related]
19. Structural and chromatographic heterogeneity of normal plasma fibrinogen associated with the presence of three gamma-chain types with distinct molecular weights.
Francis CW; Kraus DH; Marder VJ
Biochim Biophys Acta; 1983 Apr; 744(2):155-64. PubMed ID: 6404305
[TBL] [Abstract][Full Text] [Related]
20. Soluble fibrin complexes: separation as a function of pH and characterization.
Benabid Y; Concord E; Suscillon M
Thromb Haemost; 1977 Feb; 37(1):144-53. PubMed ID: 14416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
